Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

4.4K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

5.8K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.8K
Bone Remodeling01:40

Bone Remodeling

40.6K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional Hydrogels for Intraoral Wound Care: Research Progress and Design Strategies.

The Chinese journal of dental research·2026
Same author

A Wet-and-Dry Research Model: Unveiling Biomechanics in Odontoblast Polarization.

International endodontic journal·2026
Same author

A Rare LAMP3 Gene Variant Drives Enhanced Epithelial Cell Apoptosis and Salivary Gland Dysfunction.

Oral diseases·2026
Same author

TRPM2 couples cell-autonomous type-I interferon signaling to pigmentation homeostasis.

bioRxiv : the preprint server for biology·2026
Same author

Caregivers' motivations for using pediatric Tuina for recurrent respiratory tract infections in young children in Southern China: a qualitative study.

BMC complementary medicine and therapies·2026
Same author

Application of artificial intelligence in oral health management: challenges and opportunities.

Frontiers in medicine·2026

Related Experiment Video

Updated: Feb 21, 2026

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

14.5K

Rapamycin promotes osteogenesis under inflammatory conditions.

Xing Li1, Bei Chang1, Banchao Wang1

  • 1Department of Oral Pathology, School and Hospital of Stomatology, Jilin University, Changchun, Jilin 130021, P.R. China.

Molecular Medicine Reports
|October 10, 2017
PubMed
Summary

Rapamycin alone does not fully induce bone cell differentiation or regeneration. However, when combined with lipopolysaccharide (LPS), rapamycin significantly enhances osteoblast differentiation and bone formation, offering potential for treating periodontitis.

More Related Videos

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

12.2K
Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro
07:51

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro

Published on: March 18, 2019

6.4K

Related Experiment Videos

Last Updated: Feb 21, 2026

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

14.5K
A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

12.2K
Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro
07:51

Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro

Published on: March 18, 2019

6.4K

Area of Science:

  • Oral Biology
  • Regenerative Medicine
  • Pharmacology

Background:

  • Chronic periodontitis leads to irreversible bone loss, posing a clinical challenge.
  • The mechanistic target of rapamycin (mTOR) pathway is implicated in osteogenic differentiation.
  • Mesenchymal stem cells (MSCs) are crucial for bone regeneration.

Purpose of the Study:

  • To investigate if rapamycin can induce osteogenic differentiation of bone marrow-derived mesenchymal stem cells (BMSCs) in vitro.
  • To evaluate rapamycin's effect on new bone formation in vivo.
  • To explore the combined effect of rapamycin and lipopolysaccharide (LPS) on osteogenesis.

Main Methods:

  • Primary BMSCs were treated with rapamycin alone or in combination with LPS.
  • Osteogenic differentiation was assessed by measuring gene expression (Sp7, RUNX2, ALP, Col I), ALP activity, and calcium nodule formation in vitro.
  • Bone regeneration was evaluated in a rat model treated with rapamycin and LPS.

Main Results:

  • Rapamycin alone did not fully induce osteoblast differentiation in vitro or significantly enhance bone regeneration in vivo.
  • Combined treatment with rapamycin and LPS significantly increased osteogenic markers and activity in BMSCs.
  • Rapamycin plus LPS treatment promoted bone regeneration in vivo in rats.

Conclusions:

  • Rapamycin alone is insufficient for inducing osteoblast differentiation and bone regeneration.
  • Rapamycin enhances osteoblast differentiation and bone formation in the context of LPS-induced inflammation.
  • Rapamycin shows potential as a therapeutic agent for periodontitis-associated bone loss.